Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:

PetMed Express (PETS) : "I like them, but I prefer Idexx Laboratories (IDXX) which has more consistency."

STMicroelectronics (STM) : "That is a good company and I love the group."

Lumentum Holdings (LITE) : "Optics are too hard for me. I'll take a pass. Go with Cisco Systems (CSCO) ."

Allergan (AGN) : "Everyone's worried about this being a down year for them."

Cramer and the AAP team are looking at new home sales data and what that means for home prices and the cost of borrowing. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Over on Real Money, Cramer says, you want a cyclical? You need a disappointment to get in one. Get more of his insights with a free trial subscription to Real Money.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To read a full recap of this episode of "Mad Money," click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in AGN.

More from Jim Cramer

Jim Cramer: A Day When the Glass Is Not Half Full but Totally Full

Jim Cramer: A Day When the Glass Is Not Half Full but Totally Full

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

PayPal, Senseonomics, Idexx Laboratories: 'Mad Money' Lightning Round

PayPal, Senseonomics, Idexx Laboratories: 'Mad Money' Lightning Round

Rewind: Jim Cramer on Tariffs, Coca Cola, Aurora Cannabis and Tyson Foods

Rewind: Jim Cramer on Tariffs, Coca Cola, Aurora Cannabis and Tyson Foods

Jim Cramer Reacts to Reports of a Coca-Cola's Possible Move Into Cannabis Drinks

Jim Cramer Reacts to Reports of a Coca-Cola's Possible Move Into Cannabis Drinks